These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2696217)

  • 1. [Therapeutic consequences of hemorheologic research].
    Ernst E
    Wien Med Wochenschr; 1989 Dec; 139(24):569-80. PubMed ID: 2696217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapy from the hemorheologic viewpoint. 1: Hemodilution and defibrinogenation].
    Ernst E
    Fortschr Med; 1986 Jun; 104(21):423-6. PubMed ID: 3732982
    [No Abstract]   [Full Text] [Related]  

  • 3. [Blood rheology in peripheral occlusive disease. Effects of hemodilution and pentoxifylline].
    Angelkort B
    Wien Med Wochenschr; 1986; 136 Spec No():29-35. PubMed ID: 3548089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of peripheral arterial occlusive disorders with rheologically active measures].
    Turowski A; Schmidt HH; Sternitzky R
    Z Arztl Fortbild (Jena); 1987; 81(17):883-8. PubMed ID: 3439205
    [No Abstract]   [Full Text] [Related]  

  • 5. [Anti-thixotropic therapy in arterial occlusive disorders: What is the effectiveness of "rheological procedures" in the presence of persisting obliterations?].
    Schmid-Schönbein H
    Wien Med Wochenschr; 1985 Aug; 135(15-16):368-79. PubMed ID: 4060740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hemorheologic, micro- and macrocirculatory effects of an infusion of 500 ml of 6% medium molecular weight hydroxyethyl starch (Haes 200,000/0.5)].
    Jung F; Waldhausen P; Mrowietz C; Spitzer S; Kiesewetter H; Wenzel E
    Infusionstherapie; 1989 Aug; 16(4):148-54. PubMed ID: 2478482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hemorheologic therapy in peripheral arterial occlusive disease].
    Kiesewetter H; Jung F
    Fortschr Med; 1984 Oct; 102(37):921-4. PubMed ID: 6500451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of hemorheology in the pathophysiology and treatment of arterial occlusive disease.
    Rieger H
    Int Angiol; 1986; 5(3):161-7. PubMed ID: 3559317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Heparin-induced extracorporeal LDL precipitation (HELP): a new therapeutic intervention in cerebrovascular diseases and peripheral arterial occlusive disease].
    Walzl B; Walzl M; Lechner P; Lechner H; Cesnik H
    Wien Med Wochenschr; 1993; 143(22):563-70. PubMed ID: 8154130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hemorheologic therapy applications in coronary heart disease].
    Leschke M; Motz W; Strauer BE
    Wien Med Wochenschr; 1986; 136 Spec No():17-24. PubMed ID: 3825169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Experiences with the clinical use of iso- and hypervolemic hemodilution in conservative therapy of vascular diseases].
    Turowski A; Schmidt H; Sternitzky R; Brehme S; Keysser G; Hiebsch G; Hiebsch U
    Vasa Suppl; 1991; 32():338-41. PubMed ID: 1771528
    [No Abstract]   [Full Text] [Related]  

  • 12. [Induced hemodilution as a new concept in the therapy of peripheral circulatory disorders].
    Rieger H
    Internist (Berl); 1982 Jul; 23(7):375-82. PubMed ID: 7049999
    [No Abstract]   [Full Text] [Related]  

  • 13. [Whole blood viscosity in patients with acral arterial occlusive diseases and their modification by rheologically active drugs].
    Runge E; Thiele P
    Z Gesamte Inn Med; 1987 Mar; 42(5):137-41. PubMed ID: 3590891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The pharmacological approach in hemorheology].
    Sarno A; Caimi G
    Ric Clin Lab; 1985; 15 Suppl 1():479-97. PubMed ID: 3898325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hemodilution].
    Landgraf H
    Wien Med Wochenschr; 1986; 136 Spec No():36-40. PubMed ID: 3548090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hemorheologic and clinical in vitro and in vivo studies of the effectiveness of isovolemic hemodilution using Gelafusal and Infukoll M40 in patients with peripheral arterial occlusive disease].
    Pöhlmann G; Braumann A; Grohmann G
    Vasa Suppl; 1991; 32():342-4. PubMed ID: 1722914
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapy with hemorheologic considerations. 2: Rheologic agents].
    Ernst E
    Fortschr Med; 1987 Feb; 105(4):69-72. PubMed ID: 3557263
    [No Abstract]   [Full Text] [Related]  

  • 18. [Results of the Berlin HOT/UVB comparative study in patients with peripheral arterial occlusive disorders].
    Paulitschke M; Turowski A; Lerche D
    Z Gesamte Inn Med; 1992 Apr; 47(4):148-53. PubMed ID: 1595300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Blood rheological changes and their clinical significance in chronic arterial obstructive disease].
    Sternitzky R; Seige K
    Z Gesamte Inn Med; 1983 Jan; 38(1):1-7. PubMed ID: 6342278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The influence of hemorrheology on the practice of clinical medicine].
    Dormandy JA
    Ric Clin Lab; 1983; 13 Suppl 3():7-27. PubMed ID: 6369497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.